Antipsychotic prescribing patterns in the Texas prison system

Jacques Baillargeon, S. A. Contreras

Research output: Contribution to journalArticle

16 Citations (Scopus)

Abstract

Although prison inmates are reported to exhibit elevated rates of psychotic disorders, little is known about antipsychotic pharmacotherapy in correctional settings. Therefore, the purpose of this study is to describe antipsychotic prescribing patterns in one of the nation's largest prison systems. The study population consisted of 3,750 Texas Department of Criminal Justice (TDCJ) inmates diagnosed with schizophrenic disorders, nonschizophrenic psychotic disorders, or both. In 1998, among inmates diagnosed with schizophrenic disorders, 14.6 percent were prescribed atypical antipsychotic agents, and 85.4 percent were prescribed typical antipsychotic agents. Among inmates diagnosed with nonschizophrenic psychotic disorders, 89.3 percent were prescribed typical antipsychotic agents, while 10.7 percent were prescribed atypical antipsychotic agents. Black males and females were prescribed atypical antipsychotic agents less frequently than their counterparts. Understanding such prescribing patterns is integral to the efficient and cost-effective planning of correctional mental health care.

Original languageEnglish (US)
Pages (from-to)48-53
Number of pages6
JournalJournal of the American Academy of Psychiatry and the Law
Volume29
Issue number1
StatePublished - 2001
Externally publishedYes

Fingerprint

Prisons
Antipsychotic Agents
correctional institution
cost planning
Psychotic Disorders
justice
mental health
health care
Schizophrenia
Criminal Law
Mental Health
Delivery of Health Care
Costs and Cost Analysis
Drug Therapy
Population

ASJC Scopus subject areas

  • Law
  • Psychiatry and Mental health

Cite this

Antipsychotic prescribing patterns in the Texas prison system. / Baillargeon, Jacques; Contreras, S. A.

In: Journal of the American Academy of Psychiatry and the Law, Vol. 29, No. 1, 2001, p. 48-53.

Research output: Contribution to journalArticle

@article{113e9bcf5a5946d49c18489026ed05bf,
title = "Antipsychotic prescribing patterns in the Texas prison system",
abstract = "Although prison inmates are reported to exhibit elevated rates of psychotic disorders, little is known about antipsychotic pharmacotherapy in correctional settings. Therefore, the purpose of this study is to describe antipsychotic prescribing patterns in one of the nation's largest prison systems. The study population consisted of 3,750 Texas Department of Criminal Justice (TDCJ) inmates diagnosed with schizophrenic disorders, nonschizophrenic psychotic disorders, or both. In 1998, among inmates diagnosed with schizophrenic disorders, 14.6 percent were prescribed atypical antipsychotic agents, and 85.4 percent were prescribed typical antipsychotic agents. Among inmates diagnosed with nonschizophrenic psychotic disorders, 89.3 percent were prescribed typical antipsychotic agents, while 10.7 percent were prescribed atypical antipsychotic agents. Black males and females were prescribed atypical antipsychotic agents less frequently than their counterparts. Understanding such prescribing patterns is integral to the efficient and cost-effective planning of correctional mental health care.",
author = "Jacques Baillargeon and Contreras, {S. A.}",
year = "2001",
language = "English (US)",
volume = "29",
pages = "48--53",
journal = "Journal of the American Academy of Psychiatry and the Law",
issn = "1093-6793",
publisher = "American Academy of Psychiatry and the Law",
number = "1",

}

TY - JOUR

T1 - Antipsychotic prescribing patterns in the Texas prison system

AU - Baillargeon, Jacques

AU - Contreras, S. A.

PY - 2001

Y1 - 2001

N2 - Although prison inmates are reported to exhibit elevated rates of psychotic disorders, little is known about antipsychotic pharmacotherapy in correctional settings. Therefore, the purpose of this study is to describe antipsychotic prescribing patterns in one of the nation's largest prison systems. The study population consisted of 3,750 Texas Department of Criminal Justice (TDCJ) inmates diagnosed with schizophrenic disorders, nonschizophrenic psychotic disorders, or both. In 1998, among inmates diagnosed with schizophrenic disorders, 14.6 percent were prescribed atypical antipsychotic agents, and 85.4 percent were prescribed typical antipsychotic agents. Among inmates diagnosed with nonschizophrenic psychotic disorders, 89.3 percent were prescribed typical antipsychotic agents, while 10.7 percent were prescribed atypical antipsychotic agents. Black males and females were prescribed atypical antipsychotic agents less frequently than their counterparts. Understanding such prescribing patterns is integral to the efficient and cost-effective planning of correctional mental health care.

AB - Although prison inmates are reported to exhibit elevated rates of psychotic disorders, little is known about antipsychotic pharmacotherapy in correctional settings. Therefore, the purpose of this study is to describe antipsychotic prescribing patterns in one of the nation's largest prison systems. The study population consisted of 3,750 Texas Department of Criminal Justice (TDCJ) inmates diagnosed with schizophrenic disorders, nonschizophrenic psychotic disorders, or both. In 1998, among inmates diagnosed with schizophrenic disorders, 14.6 percent were prescribed atypical antipsychotic agents, and 85.4 percent were prescribed typical antipsychotic agents. Among inmates diagnosed with nonschizophrenic psychotic disorders, 89.3 percent were prescribed typical antipsychotic agents, while 10.7 percent were prescribed atypical antipsychotic agents. Black males and females were prescribed atypical antipsychotic agents less frequently than their counterparts. Understanding such prescribing patterns is integral to the efficient and cost-effective planning of correctional mental health care.

UR - http://www.scopus.com/inward/record.url?scp=0035069260&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0035069260&partnerID=8YFLogxK

M3 - Article

VL - 29

SP - 48

EP - 53

JO - Journal of the American Academy of Psychiatry and the Law

JF - Journal of the American Academy of Psychiatry and the Law

SN - 1093-6793

IS - 1

ER -